Clinical Trial Update: Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating azacitidine in combination with donor lymphocyte infusion to prevent relapse of acute myeloid leukemia after transplantation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Acute Myeloid Leukemia (AML), Relapse | Phase 2 | Status: NOT_YET_RECRUITING